|4.985Mins Read
Beyond the Microscope: How Pathology Labs Embrace AI Adoption
- Authors
- Name
- Geeks Kai
- @KaiGeeks
Loading share buttons...
Loading content...
The gold standard of pathology has been the same for over a hundred years: a highly skilled physician examining a tissue sample under a glass microscope, colored pink and purple. Although the process has been adequate for the field, the amount of samples and the nature of modern precision medicine have stretched the limits of the process.
Today, there is a quiet revolution that is taking place. Pathology labs are no longer simply rooms lined with microscopes. Instead, they are being transformed into cutting-edge data centers. The addition of Artificial Intelligence technology is changing the profession from being subjective and qualitative to objective and scientific. This, in no way, replaces the pathologist but gives them technology that allows them to diagnose faster and more accurately than before.
The application of AI in the field of pathology starts with the concept of digitization. In other words, before an algorithm can analyze a sample, the physical glass slide needs to be converted into a digital file. This is achieved by a process called Whole Slide Imaging (WSI), which generates enormous files, often gigabytes in size, which contain all the cellular information.
As soon as the lab becomes digitalized, the following benefits of using artificial intelligence become apparent:
As labs enter 2026, applications for AI have shifted from research prototypes to diagnostic assistants that have become essential.
In the field of oncology, the grade of the tumor or the expression of particular biomarkers is an important factor to consider when selecting the appropriate treatment. In the past, pathologists had to rely on manual cell counting or estimation of percentages, which was a cumbersome and sometimes inaccurate process. Today, computers using AI algorithms can count thousands of cells within seconds.
All lab cases are not the same. While a routine screening for a healthy patient can wait, a probable aggressive cancer requires urgent processing. AI-based solutions can review incoming slides in the background and prioritize the probable cases at the front of the pathologist's electronic worklist. This intelligent prioritization helps minimize turnaround times for urgent diagnoses.
One of the most promising areas of AI research is the ability it gives us to "see" things that the human eye cannot. Sophisticated machine learning algorithms are now able to recognize tiny patterns of cell distribution that are related to the likelihood of a particular drug being effective or the likelihood of cancer recurrence. This is making the traditional slide a powerful predictor of genomic activity.
There are still some challenges to overcome on the journey to a completely AI-integrated lab.
Storage Requirements of Data: The storage of data from a day’s presentations can be terabytes. This requires investment in cloud infrastructure or supercomputers to be able to deal with the data.
The Black Box Problem: A pathologist would have to trust an AI if they could understand why it made a certain suggestion. The current trend in the industry is towards Explainable AI, which gives a visual map showing which cells the algorithm has identified in its conclusion.
Regulatory and Ethics Guidelines: With the growing role of AI from an enabling tool to a diagnostic assistant, there has been an emphasis from regulatory agencies on stringent guidelines to ensure these tools function in a safe, unbiased, and effective manner.
Though the algorithms themselves receive the bulk of the publicity, they cannot function in isolation. It is when they are integrated into the fabric of the lab on a daily basis that their true value is achieved. This is where the role of modern lab management software is so important.
The problem with legacy systems is that they are not able to cope with the burden of digital images and metadata from artificial intelligence. However, a new breed of software companies has emerged that has filled this gap. These companies provide integrated platforms that serve as a single source of truth, which enables pathologists to access digital slides, run artificial intelligence algorithms, and sign off reports in one interface.
Companies like NovoPath are at the forefront of this revolution with cloud-native solutions that are developed in a way that makes them immediately compatible with AI integration. Rather than requiring pathologists to navigate between different computer programs, these sophisticated tools incorporate the results of the AI directly into the process. Thus, the information is not merely a peripheral addition but a resource that improves the efficiency of the lab and the treatment of the patient. As we move towards the end of the decade, the question isn’t when a lab will implement AI, but rather how quickly they can do it to remain relevant in this ever-digital world. The future of pathology is bright, digital, and most definitely intelligent.
Learn more about Novopath's approach to digital pathology and AI here: https://www.novopath.com/guides/the-practical-guide-to-operationalizing-digital-pathology-ai-in-the-lab/